537 related articles for article (PubMed ID: 19574671)
21. The role of high-risk HPV-DNA testing in the male sexual partners of women with HPV-induced lesions.
Giraldo PC; Eleutério J; Cavalcante DI; Gonçalves AK; Romão JA; Eleutério RM
Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):88-91. PubMed ID: 17485158
[TBL] [Abstract][Full Text] [Related]
22. Physical status of multiple human papillomavirus genotypes in flow-sorted cervical cancer cells.
Vermeulen CF; Jordanova ES; Szuhai K; Kolkman-Uljee S; Vrede MA; Peters AA; Schuuring E; Fleuren GJ
Cancer Genet Cytogenet; 2007 Jun; 175(2):132-7. PubMed ID: 17556069
[TBL] [Abstract][Full Text] [Related]
23. Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions.
Jendoubi-Ferchichi M; Satouri L; Ghoul F; Malek-Mellouli M; Derbel AM; Makni MK; Reziga H; Baba A; Zili M; Segondy M; Khelifa R
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3361-3366. PubMed ID: 30583341
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
Bao YP; Li N; Smith JS; Qiao YL
Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
[TBL] [Abstract][Full Text] [Related]
25. Detection of high-risk human papillomavirus type 16/18 in cutaneous warts in immunocompetent patients, using polymerase chain reaction.
Payal R; Gupta S; Aggarwal R; Handa S; Radotra BD; Arora SK
Dermatol Online J; 2006 Oct; 12(6):1. PubMed ID: 17083881
[TBL] [Abstract][Full Text] [Related]
26. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
27. Detection of human papillomavirus from archival tissues in cervical cancer patients in Mauritius.
Rughooputh S; Eddoo R; Manraj S; Jeebun N; Greenwell P
J Clin Virol; 2006 Feb; 35(2):173-8. PubMed ID: 16115796
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of human papillomavirus in Mazandaran Province, Islamic Republic of Iran.
Hamkar R; Azad TM; Mahmoodi M; Seyedirashti S; Severini A; Nategh R
East Mediterr Health J; 2002 Nov; 8(6):805-11. PubMed ID: 15568458
[TBL] [Abstract][Full Text] [Related]
29. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
30. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
McKenzie ND; Kobetz EN; Hnatyszyn J; Twiggs LB; Lucci JA
Gynecol Oncol; 2010 Mar; 116(3):572-7. PubMed ID: 19906410
[TBL] [Abstract][Full Text] [Related]
31. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus prevalence in invasive cervical carcinomas in Bulgaria.
Todorova I; Ganchev G; Shikova E
J Clin Pathol; 2010 Dec; 63(12):1121-3. PubMed ID: 20943820
[TBL] [Abstract][Full Text] [Related]
33. [Study on the relationship between genesis and development of cervical cancer and the infection of human papillomavirus type 16/18, human herpesvirus II and cytomegalovirus].
Qian YS; Lv W; Sui LH; Wang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Aug; 26(8):622-5. PubMed ID: 16390015
[TBL] [Abstract][Full Text] [Related]
34. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery.
Lai CH; Chang CJ; Huang HJ; Hsueh S; Chao A; Yang JE; Lin CT; Huang SL; Hong JH; Chou HH; Wu TI; Huang KG; Wang CC; Chang TC
J Clin Oncol; 2007 Aug; 25(24):3628-34. PubMed ID: 17704412
[TBL] [Abstract][Full Text] [Related]
35. Differences in human papillomavirus type may influence clinical outcome in early stage cervical cancer.
Dahlgren L; Erlandsson F; Lindquist D; Silfverswärd C; Hellström AC; Dalianis T
Anticancer Res; 2006; 26(2A):829-32. PubMed ID: 16619476
[TBL] [Abstract][Full Text] [Related]
36. A novel multiplex real-time PCR assay for the detection and quantification of HPV16/18 and HSV1/2 in cervical cancer screening.
Zhao Y; Cao X; Tang J; Zhou L; Gao Y; Wang J; Zheng Y; Yin S; Wang Y
Mol Cell Probes; 2012 Apr; 26(2):66-72. PubMed ID: 22293505
[TBL] [Abstract][Full Text] [Related]
37. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
Brotherton JM
Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
[TBL] [Abstract][Full Text] [Related]
38. Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer.
Ueda M; Hung YC; Chen JT; Chiou SH; Huang HH; Lin TY; Terai Y; Chow KC
Gynecol Oncol; 2006 Aug; 102(2):173-81. PubMed ID: 16427687
[TBL] [Abstract][Full Text] [Related]
39. [Prevalence of HPV infection in precancerous and cancerous lesions of the uterine cervix in Tunisia].
Missaoui N; Hmissa S; Trabelsi A; Tahar Yacoubi M; Nouira A; Frappart L; Mokni M; Korbi S
Ann Biol Clin (Paris); 2010; 68(3):297-303. PubMed ID: 20478773
[TBL] [Abstract][Full Text] [Related]
40. The HPV16 transcriptome in cervical lesions of different grades.
Schmitt M; Dalstein V; Waterboer T; Clavel C; Gissmann L; Pawlita M
Mol Cell Probes; 2011; 25(5-6):260-5. PubMed ID: 21664454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
